Market Overview:
The global Bone Morphogenetic Proteins 7 market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of bone diseases, increasing demand for minimally invasive surgeries and growing awareness about bone morphogenetic proteins 7. Based on type, the global Bone Morphogenetic Proteins 7 market is segmented into sponge and gel. Sponge is expected to account for a larger share of the market than gel during the forecast period owing to its advantages such as easy handling and less surgical time. Based on application, spinal fusion surgery accounted for a larger share of the global Bone Morphogenetic Proteins 7 market in 2017 than trauma surgery, oral maxillofacial surgery and reconstructive surgery. This can be attributed to factors such as rising incidence of spine-related disorders and increasing demand for minimally invasive surgeries.
Product Definition:
Bone morphogenetic proteins (BMPs) are a family of secreted signaling molecules that play important roles in the development and regeneration of bone and cartilage. There are currently seven known BMPs in mammals: BMP-1, -2, -3, -4, -5, -6, and –7.
Sponge:
Sponge is a device used to collect bone morphogenetic proteins (BMP) from the culture medium. It's usage in BMP7 research is significant as it helps in measuring protein production and its purity. The most commonly used sponges are bovine trachea, porcine kidney, chicken egg white and Chinese Hamster Ovary (CHO).
Gel:
Gel is a colloidal drug delivery system that consists of an organic polymer in an aqueous solution. The gel has the ability to maintain its physical and chemical properties during the transit through biological tissues. It can be used for local as well as systemic treatment of various diseases. Gel formsaldehyde, which has been widely used in bone morphogenetic proteins 7 (BMP-7) market owing to its high efficiency, low toxicity, and biocompatibility characteristics.
Application Insights:
The spinal fusion segment dominated the global market in 2017. The growing geriatric population, coupled with an increase in the number of spinal disorders, is anticipated to drive demand over the forecast period. According to a study published by WHO, it was estimated that approximately 300,000 people die due to road accidents annually worldwide. Moreover, as per WHO estimates nearly 1 million people are hospitalized every year due to road injuries and around 10-30 million people are disabled or maimed each year globally. Thus rising incidences of spine disorders are expected to boost product demand during the forecast period (2018-2030).
Trauma surgery accounted for a significant share in 2017 owing bone morphogenetic proteins¢â‚¬â„¢ ability to stimulate healing & regeneration at an early stage thereby aiding faster recovery process after trauma surgeries such as hip fractures and compound fracture of arms & legs.
Regional Analysis:
North America dominated the global bone morphogenetic proteins market in 2017. The presence of a large number of industry players and high adoption rate for advanced technologies are some factors contributing to the growth of this regional market. In addition, increasing demand for minimally invasive surgeries is also expected to drive growth over the forecast period.
The Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure by governments and private sectors in countries such as China, India, South Korea, Singapore and Japan. Moreover, growing medical tourism due to low treatment cost coupled with favorable government policies regarding reimbursement is further expected boost revenue generation capacity in this region during the forecast period from 2018-2030 (USD X billion).
Growth Factors:
- Increasing demand for bone grafts and implants due to rising incidence of bone fractures and other orthopedic disorders.
- Growing awareness about the benefits of BMP-7 therapy among surgeons and patients.
- Rising investment in research and development activities for novel BMP-7 products.
- Technological advancements in the field of regenerative medicine that are expected to increase the adoption of BMP-7 products.
- increasing number of clinical studies evaluating the efficacy of BMP-7 therapy in various indications
Scope Of The Report
Report Attributes
Report Details
Report Title
Bone Morphogenetic Proteins 7 Market Research Report
By Type
Sponge, Gel
By Application
Spinal Fusion, Trauma Surgery, Oral Maxillofacial Surgery, Reconstructive
By Companies
Stryker, Ember Therapeutics, Medtronic, Cellumed Co., Ltd., DePuy Synthes, Integra Lifesciences Holdings Corporation, R&D Systems, Merck KGaA, Smith and Nephew, Inc., Thermo Fischer Scientific, Zimmer Biomet Holdings, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
157
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Bone Morphogenetic Proteins 7 Market Report Segments:
The global Bone Morphogenetic Proteins 7 market is segmented on the basis of:
Types
Sponge, Gel
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Spinal Fusion, Trauma Surgery, Oral Maxillofacial Surgery, Reconstructive
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Stryker
- Ember Therapeutics
- Medtronic
- Cellumed Co., Ltd.
- DePuy Synthes
- Integra Lifesciences Holdings Corporation
- R&D Systems
- Merck KGaA
- Smith and Nephew, Inc.
- Thermo Fischer Scientific
- Zimmer Biomet Holdings, Inc.
Highlights of The Bone Morphogenetic Proteins 7 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sponge
- Gel
- By Application:
- Spinal Fusion
- Trauma Surgery
- Oral Maxillofacial Surgery
- Reconstructive
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bone Morphogenetic Proteins 7 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bone morphogenetic proteins 7 (BMP7) are a family of proteins that play an important role in the development and growth of bones. BMP7 helps to create new bone cells by signaling other cells to change their behavior. This process is known as bone remodeling.
Some of the key players operating in the bone morphogenetic proteins 7 market are Stryker, Ember Therapeutics, Medtronic, Cellumed Co., Ltd., DePuy Synthes, Integra Lifesciences Holdings Corporation, R&D Systems, Merck KGaA, Smith and Nephew, Inc., Thermo Fischer Scientific, Zimmer Biomet Holdings, Inc..
The bone morphogenetic proteins 7 market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bone Morphogenetic Proteins 7 Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bone Morphogenetic Proteins 7 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bone Morphogenetic Proteins 7 Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bone Morphogenetic Proteins 7 Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bone Morphogenetic Proteins 7 Market Size & Forecast, 2020-2028
4.5.1 Bone Morphogenetic Proteins 7 Market Size and Y-o-Y Growth
4.5.2 Bone Morphogenetic Proteins 7 Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Sponge
5.2.2 Gel
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Spinal Fusion
6.2.2 Trauma Surgery
6.2.3 Oral Maxillofacial Surgery
6.2.4 Reconstructive
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bone Morphogenetic Proteins 7 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bone Morphogenetic Proteins 7 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Sponge
9.6.2 Gel
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Spinal Fusion
9.10.2 Trauma Surgery
9.10.3 Oral Maxillofacial Surgery
9.10.4 Reconstructive
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Sponge
10.6.2 Gel
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Spinal Fusion
10.10.2 Trauma Surgery
10.10.3 Oral Maxillofacial Surgery
10.10.4 Reconstructive
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Sponge
11.6.2 Gel
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Spinal Fusion
11.10.2 Trauma Surgery
11.10.3 Oral Maxillofacial Surgery
11.10.4 Reconstructive
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Sponge
12.6.2 Gel
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Spinal Fusion
12.10.2 Trauma Surgery
12.10.3 Oral Maxillofacial Surgery
12.10.4 Reconstructive
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Sponge
13.6.2 Gel
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Spinal Fusion
13.10.2 Trauma Surgery
13.10.3 Oral Maxillofacial Surgery
13.10.4 Reconstructive
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bone Morphogenetic Proteins 7 Market: Competitive Dashboard
14.2 Global Bone Morphogenetic Proteins 7 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Stryker
14.3.2 Ember Therapeutics
14.3.3 Medtronic
14.3.4 Cellumed Co., Ltd.
14.3.5 DePuy Synthes
14.3.6 Integra Lifesciences Holdings Corporation
14.3.7 R&D Systems
14.3.8 Merck KGaA
14.3.9 Smith and Nephew, Inc.
14.3.10 Thermo Fischer Scientific
14.3.11 Zimmer Biomet Holdings, Inc.
